Methodology
Executive Summary
In part three of our series, we analyzed the outcomes of terminated deals in terms of the products that advanced in the clinic or went on to be approved post-termination.
You may also be interested in...
Safety First For Perrigo In CBD Market; ‘Long-Term’ Play Starts With Clinical Trials
Perrigo’s clinical trials on CBD likely will take years before resulting products help bring order to the market. During earnings presentation, CEO Murray Kessler says the trials aren’t intended to establish claims for CBD but are more a long-term effort to provide data to FDA.
With CBD Products Unlawful, FDA Enforcement Policy Guidance Has No Economic Significance
As draft guidance receives OMB review, FDA’s determination of no economic significance reflects its official position that the thousands of supplements, food and personal care products containing CBDs available in the US are unlawful.
QUOTED. 8 August 2020. Ashley Wittorf.
AdvaMed Accell executive director Ashley Wittorf spoke in support of a proposed US House bill that would give financial help to small companies making products to address COVID-19.
Need a specific report? 1000+ reports available
Buy Reports